Elevated levels of interleukin-6 (IL-6) prior to surgery to create an ... hypertension, ischemic heart disease, and peripheral arterial disease, according to the investigators.

Objective Neutralising pro-inflammatory interleukin-6 (IL-6) may effectively treat Crohn’s disease (CD). Effects of PF-04236921, an anti-IL-6 antibody, in adults with CD are reported. Results 247 ...

MM disease progression often includes the development of drug ... Such soluble factors include interleukin 6 (IL-6), insulin-like growth factor-1 (IGF-1), stromal cell-derived factor-1 (SDF-1), tumor ...

There is no specific laboratory test for the disease, and thus the diagnosis of PMR depends on ... 2 All these data strongly support the rationale for targeting IL-6 in PMR and/or GCA. Thus, ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

Scientists explore how the immune and nervous systems constantly communicate, influencing brain diseases, behavior, and ...

Researchers found that while sweat biomarkers remain stable, plasma biomarkers show significant inflammatory changes after a ...

Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) production, leads to a significant and sustained ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an osteoarthritis treatment in human trials may have potential for treating RA.

Vaxcyte (NASDAQ:PCVX – Get Free Report) and Tourmaline Bio (NASDAQ:TRML – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Rising air pollution, changes in hormone levels, immune system imbalances and longer life expectancy are increasing the risk ...